Tirzepatide 10mg — Dual GIP/GLP-1 Receptor Agonist for Metabolic Research

Tirzepatide is a synthetic 39-amino-acid linear peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. A C20 fatty diacid moiety conjugated via a linker at Lys20 confers albumin binding and an extended half-life. The dual incretin mechanism is studied for its combined effect on insulin secretion, glucose disposal, gastric emptying, and appetite regulation in experimental metabolic models.

Specifications

Scientific nameTirzepatide Acetate
CAS number2023788-19-2
Molecular formulaC225H348N48O68
Molecular weight4813.45 g/mol
SequenceTyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
FormLyophilized Powder
HPLC purity99.5%

Pricing (10-vial research packs)

Research applications

Storage

Store lyophilized powder at -20°C for up to 2 years. Protect from ambient humidity and direct sunlight. Once reconstituted, store at 2°C to 8°C (refrigerated) and use within 14 days.

Reconstitution

Add 2.0 mL of Sterile Bacteriostatic Water slowly down the inside wall of the vial. Do not spray directly onto the powder. Swirl gently in a circular motion until a clear, colorless solution forms. Do not shake.

Free tracked shipping to all 50 US states — received within 10 working days. Lost or damaged parcels are replaced free of charge. 30-day refund policy.

For laboratory research use only. Products are not approved by the FDA or EMA for human or veterinary use, and are not drugs, dietary supplements or cosmetics.